Product category:
Pharmaceutical Processing News
News Release from: Cenexi | Subject: Outsourcing
Edited by the Processingtalk Editorial
Team on 05 October 2007
Outsourcing production of injectable
ampoules
If a production line becomes incapable of delivering products that meet new regulatory requirements, it is difficult for pharmaceutical companies to justify the investment to upgrade or replace it
Therefore, outsourcing the production of injectable ampoules to a specialist contractor is viewed as the most efficient and cost-effective solution for pharmaceutical companies wishing to offer fully compliant products at the minimum possible cost Contract manufacturer, Cenexi, builds a case to justify outsourcing production and to help choose the right contractor
This article was originally published on Processingtalk on 16 Oct 2007 at 8.00am (UK)
Related stories
Reduce costs by outsourcing ampoule production
As regulatory requirements increase, market prices fall and production costs increase, sterile ampoule manufacturers have realized that it is far more cost-effective to outsource production
Outsourcing service for Pharmaceutical solvents
Cenexi, the European leader in manufacturing injectable ampoules, introduces a new service for pharmaceutical companies who require solvents in injectable ampoules
It has been estimated that pharmaceutical companies would need to invest around euro10 million in order to install the new or upgraded injectable ampoule production lines now needed.
With the global contract manufacturing market expected to exceed $26bn by 2011, it is important for contract manufacturers to offer innovative, real-time services to stay ahead of the competition.
The cleanliness of the manufacturing site must always be of the highest quality, ensuring constant sterility of the water and air-conditioning system, that personnel wear protective clothing at all times and that the machines are constantly turned on even at weekends and holidays.
Further reading
Production pressures cured by contract
As the pharmaceutical sector struggles with pressures and global competition, Cenexi examines the pros and cons of outsourced manufacturing
See the world's largest mass flow meter with Able
Able will be exhibiting at the largest oil and gas industry sector exhibition, Offshore Europe 2003, with the largest ever mass flow meter: see it in Aberdeen for 4 days from 2-5 September 2003
Website dedicated to spreadsheet validation
ABB Process Solutions and Wimmer Systems are very excited to announce the release of a new website dedicated to spreadsheet validation
All equipment must also be sterilised prior to contact with the ampoules.
These processes are put in place to reduce the risk of contamination from dust particles and dirt.
By taking all these safety measures, class C cleanliness is achieved.
Such a high level of cleanliness is very expensive to maintain thus increasing the running costs of the plant.
This considerable financial burden is therefore lifted from pharmaceutical companies who outsource their ampoule production, thus freeing up funds and production space, that can be diverted for higher margin products.
Additionally, regulations require that no impurities be found in ampoules.
Therefore, a high standard quality control process must be established.
This is an additional cost burden to pharmaceutical companies.
At Cenexi, expensive optical inspection equipment is employed that allows the detection of three main non-conformities, while a separate, random check is carried out at the end of the line by a member of staff.
Cenexi uses a pinhole detection machine for ampoules and vials that features a high voltage electrical field, and impedance measurement to examine each container at four inspection points, for hairline fissures and pinholes, leaking ampoule neck tips, insufficient glass thickness at the tip and absence of fill.
The machines are very expensive, using the latest in high frequency, high voltage technology ensuring the reliable, accurate and non-destructive inspection required to comply with rigorous, strict industry standards for high-quality, safe products.
Another advantage when transferring production to a contract supplier is that the existing production line can remain in use while work is processed, in order to establish and validate the contractor facilities.
This helps minimise the risk of supply interruptions.
An alternative solution for the pharmaceutical company would be to build up large stocks of certain drugs, but this approach is costly, inconvenient and in the case of short-lived products it may even be impossible.
Cenexi offers a complete solution from manufacturing to delivery as well as employing a dedicated team who deals with the regulation requirement registrations of injectable ampoules worldwide.
Pharmaceutical companies outsourcing their ampoule production to Cenexi will be able to focus on the market, letting a reliable and resourceful partner take care of their supply needs. Request a free brochure from Cenexi ...
• Cenexi: contact details and other news
• Email this article to a colleague
• Register for the free Processingtalk email newsletter
• Processingtalk Home Page
Search the Pro-Talk network of sites
